BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21642828)

  • 1. Implications of over-the-counter proton pump inhibitors for patient counseling by pharmacists.
    Simonson W
    Am J Ther; 2013; 20(6):676-84. PubMed ID: 21642828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.
    Boardman HF; Heeley G
    Int J Clin Pharm; 2015 Oct; 37(5):709-16. PubMed ID: 26100836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.
    Boardman HF; Delaney BC; Haag S
    Curr Med Res Opin; 2015; 31(7):1309-18. PubMed ID: 25950642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of nonprescription medicines among elderly patients with chronic illness and their need for pharmacist interventions.
    Guirguis K
    Consult Pharm; 2010 Jul; 25(7):433-9. PubMed ID: 20601348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.
    Holtmann G; Bigard MA; Malfertheiner P; Pounder R
    Int J Clin Pharm; 2011 Jun; 33(3):493-500. PubMed ID: 21472476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based treatment of frequent heartburn: the benefits and limitations of over-the-counter medications.
    McRorie JW; Gibb RD; Miner PB
    J Am Assoc Nurse Pract; 2014 Jun; 26(6):330-9. PubMed ID: 24825071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of OTC omeprazole].
    Labenz J; Willmer C
    MMW Fortschr Med; 2012 Dec; 154 Suppl 4():110-4. PubMed ID: 23326929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the primary care provider in the diagnosis and management of heartburn.
    Kushner PR
    Curr Med Res Opin; 2010 Apr; 26(4):759-65. PubMed ID: 20095795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study.
    Hanna LA; Hughes C
    Int J Pharm Pract; 2012 Dec; 20(6):358-66. PubMed ID: 23134094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
    Kushner PR; Peura DA
    Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn.
    Fendrick AM; Shaw M; Schachtel B; Allgood L; Allgood G; Grender J; Peura D
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):17-21. PubMed ID: 15017628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
    Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Care in the Twenty First Century: A Vital Role for the Pharmacist.
    Bell J; Dziekan G; Pollack C; Mahachai V
    Adv Ther; 2016 Oct; 33(10):1691-1703. PubMed ID: 27535290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
    Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
    Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy placement of nonprescription nicotine replacement therapy products and community pharmacists' counseling for product use.
    Kilfoy BA; Prokhorov AV; Hudmon KS
    J Am Pharm Assoc (2003); 2006; 46(6):723-8. PubMed ID: 17176688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
    Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
    Peura D; Le Moigne A; Pollack C; Nagy P; Lind T
    Postgrad Med; 2016 Aug; 128(6):577-83. PubMed ID: 27331882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.